Country websites:


The medical device and therapy related information on this website is aimed exclusively at healthcare professionals.

Not all products are cleared or available for sale in all countries.

By clicking on the button "Accepted and Confirmed" you assure that you have taken note of this information and that you are a healthcare professional.

Volume control in peritoneal dialysis

Doctor holding filter

A practical way to assess and help correct fluid status

  • Quickly assess fluid status and recognize the trend
  • Make therapeutic changes earlier
  • Effortlessly use a wider range of practical volume control tools

Key features

Volume control — Three steps for better volume control

steps for better volume control

Assess status and trend

BCM-Body Composition Monitor
BCM-Body Composition Monitor

Routinely assess fluid status

The easy-to-use BCM-Body Composition Monitor is a powerful addition to the routine evaluation of your patients and is becoming a standard in leading PD centers.

By providing you with a more precise picture of actual fluid status through quantified overhydration, this state-of-the-art technology helps you manage the fluid status of your patients better.

Analyze the fluid status trend

The BCM-Body Composition Monitor can be used effectively to continually monitor changes and trend of the fluid status over time. Trend analysis can provide important feedback and guidance on therapy decision-making by you and your staff.1

Volume status improvement as a result of awareness2

Optimize output

Adapted PD promotes both the process of UF and clearance


EuroBCM Study maintaining euvolemia in PD

EuroBCM Study results1

Out of 639 patients from 28 centers in 6 countries:

  • 40% were normohydrated
  • 7% were dehydrated
  • 53% were overhydrated

Important factors to consider in fluid status:

Fluid status is mainly the result of the balance of intake and output over time
Fluid Status balance

Related content

1 Van Biesen W, Williams JD, Covic AC, Fan S, Claes K, et al. (2011) Fluid Status in Peritoneal Dialysis Patients: The European Body Composition Monitoring (EuroBCM) Study Cohort. PLoS ONE 6(2): e17148. doi:10.1371/journal.pone.0017148
2 Luo Y, Lu X, Woods F, Wang T. Volume Control in Peritoneal Dialysis Patients Guided by Bioimpedance Spectroscopy Assessment. Blood Purification 2011;31:296-302.
3  Fischbach M, Issad B, Dubois V, and Taamma R. The beneficial influence on the effectiveness of automated peritoneal dialysis of varying the dwell time (short/long) and fill volume (small/large): randomized controlled trial. Peritoneal Dialysis International 2011; 31(4):450-8.
4 Kim S, Oh J, Kim S, Chung W, Ahn C, Kim SG, Oh KH. Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study. Nephrol Dial Transplant 2009;24(9):2899-90.
5 Haag-Weber M, Krämer R, Haake R, Islam MS, Prischl F, Haug U, Nabut JL, Deppisch R. Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study. On behalf of the DIUREST Study Group. Nephrology Dialysis Transplantation 2010;25(7):2288-96.
6 Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C,Passlick-Deetjen J; Euro Balance Trial Group. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney International 2004;66(1):408-18.
7 Weiss L, Stegmayr B, Malmsten G, Tejde M, Hadimeri H, Siegert CE, Ahlmén J, Larsson R, Ingman B, Simonsen O, van Hamersvelt HW, Johansson AC, Hylander B, Mayr M, Nilsson PH, Andersson PO, De los Rios T. Biocompatibility and tolerability of a purely bicarbonate-buffered peritoneal dialysis solution. Peritoneal Dialysis International 2009;29(6):630-633.
8 Rippe B, Simonsen O, Heimbürger O, Christensson A, Haraldsson B, et al. Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney International 2001;59(1):348-57.